These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma. Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454 [TBL] [Abstract][Full Text] [Related]
25. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Grice J; Ek M; Greer B; Koh WJ; Muntz HG; Cain J; Tamimi H; Stelzer K; Figge D; Goff BA Gynecol Oncol; 1998 Apr; 69(1):69-73. PubMed ID: 9571001 [TBL] [Abstract][Full Text] [Related]
26. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma. Bristow RE; Duska LR; Montz FJ Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657 [TBL] [Abstract][Full Text] [Related]
27. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging? Kwon JS; Abrams J; Sugimoto A; Carey MS Int J Gynecol Cancer; 2008; 18(4):820-4. PubMed ID: 17892450 [TBL] [Abstract][Full Text] [Related]
28. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study. Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Fuso L; Sartori E Int J Gynecol Cancer; 2012 Oct; 22(8):1355-60. PubMed ID: 22976496 [TBL] [Abstract][Full Text] [Related]
29. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948 [TBL] [Abstract][Full Text] [Related]
33. Outcome of recurrent uterine papillary serous carcinoma treated with platinum-based chemotherapy. Mahdi H; Rizzo A; Rose PG Int J Gynecol Cancer; 2015 Mar; 25(3):467-73. PubMed ID: 25695549 [TBL] [Abstract][Full Text] [Related]
34. Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma. Einstein MH; Frimer M; Kuo DY; Reimers LL; Mehta K; Mutyala S; Huang GS; Hou JY; Goldberg GL Gynecol Oncol; 2012 Jan; 124(1):21-5. PubMed ID: 22035806 [TBL] [Abstract][Full Text] [Related]
35. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; VillĂ S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A; Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209 [TBL] [Abstract][Full Text] [Related]